<?xml version="1.0" encoding="UTF-8"?>
<ref id="B14">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Deshmukh</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Nakagawa</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Higashi</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Vincek</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Venkatesh</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Ruiz De Galarreta</surname>
    <given-names>M.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2018</year>). 
  <article-title>Cell type-specific pharmacological kinase inhibition for cancer chemoprevention.</article-title>
  <source>
   <italic>Nanomedicine</italic>
  </source>
  <volume>14</volume>
  <fpage>317</fpage>â€“
  <lpage>325</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.nano.2017.11.004</pub-id>
  <?supplied-pmid 29157977?>
  <pub-id pub-id-type="pmid">29157977</pub-id>
 </mixed-citation>
</ref>
